← Renée (Ren) Mayne

What podcasts say about Renée (Ren) Mayne

Every statement, with the speaker, the exact quote and the moment it was said.

What Renée (Ren) Mayne has said on podcasts

31 statements · 19 positive · 6 negative · 4 mixed · 2 neutral

  1. Moderna has made substantial progress against cancer but has not cured it.

    “Moderna certainly didn't cure cancer, but it has taken a big whack at it, I think.”

    Listen at 0:07

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  2. on Moderna sharesPositiveAug 23, 2026· Equity Mates Investing Podcast

    Moderna shares rose 177% in one day after the announcement.

    “Shares jumped 177% in a day.”

    Listen at 2:52

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  3. on Moderna sharesNegativeAug 23, 2026· Equity Mates Investing Podcast

    Moderna remains 60% below its all-time high despite its recent gain.

    “Even after its 177% gain, it's still down 60% from its all-time highs.”

    Listen at 3:17

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  4. on ModernaNegativeAug 23, 2026· Equity Mates Investing Podcast

    Moderna short interest was approximately 13.5% of free float.

    “short interest in Moderna's shares was about 13.5% of shares on issue, of free float.”

    Listen at 4:43

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  5. on AI-enabled drug discoveryPositiveAug 23, 2026· Equity Mates Investing Podcast

    AI-enabled drug discovery and genomic analysis will produce major breakthroughs.

    “There is some incredible breakthroughs coming.”

    Listen at 8:03

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  6. on Late-stage clinical trialsNegativeAug 23, 2026· Equity Mates Investing Podcast

    Late-stage clinical trials remain costly, burdensome, and regulatory-intensive.

    “late stage clinical trials is still an incredibly burdensome and costly and regulatory, regulatorily intensive choke point.”

    Listen at 8:53

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  7. Large pharmaceutical companies will ultimately prevail at regulatory bottlenecks.

    “that's where the big pharmaceutical companies are still going to ultimately win. Come out on top.”

    Listen at 9:31

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  8. on Equitymates community portfolioPositiveAug 23, 2026· Equity Mates Investing Podcast

    The community portfolio is up 8.2% year to date.

    “Our portfolio is up 8.2% year to date.”

    Listen at 10:45

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  9. Scorpio Tankers has traded at a single-digit P/E with strong dividends.

    “It's been always on single-digit PE with really good dividends.”

    Listen at 14:30

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  10. Scorpio Tankers currently trades at five times earnings.

    “It currently trades on a five price to earnings.”

    Listen at 15:26

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  11. Scorpio Tankers has $1.3 billion in net cash.

    “It has 1.3 billion net cash on its balance sheet”

    Listen at 15:29

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  12. on Oil tanker pricesMixedAug 23, 2026· Equity Mates Investing Podcast

    Oil tanker prices are currently near a cyclical peak.

    “right now we're kind of peak cycle for oil tanker prices.”

    Listen at 17:03

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  13. Scorpio Tankers’ P/E could rise from five to 15 if shipping rates normalize.

    “a five times price to earnings shipping stock can become a 15 times price to earnings shipping stock very quickly if rates sort of move down back to more normal levels.”

    Listen at 18:15

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  14. Scorpio Tankers should not be added to the community portfolio now.

    “I don't think we put it in the portfolio”

    Listen at 19:22

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  15. on Buying favored stocksPositiveAug 23, 2026· Equity Mates Investing Podcast

    Investors should not delay buying a favored stock that beats available alternatives.

    “if you find a stock, if you like it, if it ticks those boxes that prices were talking about, you know, like it's better than what other options you have available. don't wait”

    Listen at 23:20

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  16. on Consistent stock purchasesPositiveAug 23, 2026· Equity Mates Investing Podcast

    Consistent purchases at different prices can build disciplined investing habits.

    “i'm trying to build the habit of consistently buying the same stocks at different price points at different times if i still like them”

    Listen at 24:20

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  17. on Investment thesisNegativeAug 23, 2026· Equity Mates Investing Podcast

    A thesis invalidated by a 10–20% price rise is probably insufficiently robust.

    “if your thesis no longer holds after the stock jumps 10% or 20%, it's probably not a good enough thesis.”

    Listen at 27:07

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  18. on Company valuationNeutralAug 23, 2026· Equity Mates Investing Podcast

    Company valuations are ranges rather than exact point estimates.

    “Every valuation is a range. Anyone who says that there is an exact value for a particular company at a particular time is being falsely precise.”

    Listen at 27:20

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  19. on Buying favored stocks around earningsPositiveAug 23, 2026· Equity Mates Investing Podcast

    Investors should keep buying favored stocks before, after, or during earnings.

    “by before earnings, by after earnings, by during earnings, find stocks you love and keep buying.”

    Listen at 27:38

    Open the episode · Moderna’s skin cancer breakthrough, a cheap stock for the Community Portfolio & can you time your investments?
  20. on US and Australian marketsPositiveAug 12, 2026· Equity Mates Investing Podcast

    US and Australian markets are at record highs, supporting continued investment.

    “The US is also hitting all-time highs and the Australian market is hitting all-time highs. It's just been good news so far. You want to be invested.”

    Listen at 0:07

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  21. on Smart watches and sleep-apnea diagnosisPositiveAug 12, 2026· Equity Mates Investing Podcast

    More smart-device use will increase awareness and sleep-apnea diagnoses.

    “the more people will know their sleep is terrible and the more diagnosis that will happen.”

    Listen at 10:25

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  22. ResMed remains a long-term compounder despite weak market sentiment.

    “it's a continued compounder ResMed, but the market seems out of love with it still.”

    Listen at 10:32

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  23. on REA GroupPositiveAug 12, 2026· Equity Mates Investing Podcast

    REA Group remains Australia’s dominant property-listing platform.

    “they are still the dominant listing platform in Australia.”

    Listen at 11:20

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  24. on Dollar-cost averaging weekdayNeutralAug 12, 2026· Equity Mates Investing Podcast

    The weekday chosen for dollar-cost averaging has little long-term impact.

    “It doesn't matter what day.”

    Listen at 14:52

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  25. on Dollar-cost averaging consistencyPositiveAug 12, 2026· Equity Mates Investing Podcast

    Consistency over decades matters more than the investment weekday.

    “It doesn't matter what day you invest because whichever day you choose to invest, you then invested for the next 30 years.”

    Listen at 18:03

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  26. on Month-end investingPositiveAug 12, 2026· Equity Mates Investing Podcast

    Studies indicate that investing late in the month may produce better entry prices.

    “the studies do seem to indicate that the back end of the month is better.”

    Listen at 21:16

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  27. on Consistent dollar-cost averagingPositiveAug 12, 2026· Equity Mates Investing Podcast

    Tax complexity does not undermine the value of consistent market investing.

    “it doesn't override the point of investing and it doesn't undermine the value of consistently dollar cost averaging into the market. So don't let it scare you off investing.”

    Listen at 27:46

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  28. on S&P 500PositiveAug 12, 2026· Equity Mates Investing Podcast

    The S&P 500 gained nearly 300% with dividends reinvested during Burry’s bearish calls.

    “The S&P 500 with dividends reinvested is up almost 300%, meaning if he had just bought the US stock market rather than betting against it, he would have forexed his money.”

    Listen at 32:12

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  29. on Short selling and market optimismMixedAug 12, 2026· Equity Mates Investing Podcast

    Consistently shorting stocks or markets is difficult, while optimism has historically produced returns.

    “It's really hard to consistently short stocks. It's even harder to short the overall market. And pessimism gets headlines. Optimism gets returns, I think, in investing.”

    Listen at 33:58

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry
  30. The market is likely to continue overcoming worries and rising over time.

    “The story of the market is a story of just overcoming all of these reasons to be worried and continue to grow higher. Nothing tells me that that is going to change.”

    Listen at 34:10

    Open the episode · 3 impressive Aussie companies, how often should you invest & don’t listen to Michael Burry

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.